Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Hibiki Path Advisors Submitted Shareholder Proposals at the 53rd Annual General Meeting of Shareholders of Japan Pure Chemical Co., Ltd. Scheduled for June 25th, 2024
-
Laurent-Perrier : Financial Press Release - Annual results 2023-2024
-
"Will leadership change at AAA NCNU spark the change needed to stop Age Discrimination?" Asks the Law Firm of GICCB
-
Prospera Provides Annual Filing Status Update
-
Kao Releases Progress Reports on its ESG Strategy—the Kirei Lifestyle Plan
-
iStaging reveals Next Generation MR experiences at VivaTech 2024.
-
Zeus North America Mining Corp. Provides Corporate Update and Highlights its Flagship Cuddy Mountain Property
-
Cloudcode AI Unveils Kaizen: An AI-Powered Open Source Solution to Revolutionize Software Testing and Code Review
-
Mitsubishi Electric to Establish Vietnamese JV for FA Products
-
BIOMEDevice Rebrands as MEDevice, Informa Markets - Engineering's Dedicated Platform to Medical Device Innovation
-
Vladimir Kush Presents His New Painting 'Mother'
-
Fairfax Announces the Passing of Ramaswamy Athappan
-
Azul and GOL Announce Codeshare Agreement
-
Loop Energy Provides Update on the Strategic Review Process
-
Imperial Announces Voting Results for the Election of Directors
-
LENNAR DFW DIVISION HOSTS HOPEKIDS EVENT FOR CHILDREN WITH LIFE-THREATENING MEDICAL CONDITIONS AT KIDZANIA USA
-
LinkDaddy Announces Use Of Ahrefs Backlink Checker For SEO Ranking Service
-
What made ASML so successful today: DIGITIMES Asia's Q&A with Dutch Journalist and author Marc Hijink
-
The World's First Five-Terminal Flexible DC Transmission Project is Undergoing a Complete Overhaul
-
Introducing Optimum AI: Revolutionizing DeFi with Text-Based Trading on WhatsApp and Telegram
-
IEHP's newly announced Community Wellness Center adds more heart to the city of San Bernardino
-
Celltrion receives European Commission approval of Omlyclo® (CT-P39), the first and only omalizumab biosimilar approved in Europe
-
/C O R R E C T I O N -- IDEAYA Biosciences, Inc./
-
ASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug Candidates
-
Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024
-
Meet New MacDroid 2.0
-
DIRECT DIGITAL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Direct Digital Holdings, Inc. and Encourages Investors to Contact the Firm
-
The 2024 ESSENCE Festival of Culture™ Celebrates 30 Years of Loving Us with Evening Performances from USHER for a Special One-Night Only 20th Anniversary of Confessions Milestone Moment, Janet Jacks
-
Lee Leads Wire-to-Wire to Win MLF General Tire Heavy Hitters 2024 Presented by Bass Pro Shops on the Kissimmee Chain of Lakes
-
Zeus North America Mining Corp. Provides Corporate Update and Highlights its Flagship Cuddy Mountain Property
-
Antengene To Present One Oral and Four Abstracts at ASCO 2024
-
CXApp Inc. (Nasdaq: CXAI) Introduces AI-based Analytics Platform CXAI VU ("SkyView") in collaboration with Google Cloud
-
Tocvan Drills Another Successful Hole Outside of Main Zone Returns High-Grade 10.9 g/t Gold over 3.1 meters, within 42.7 meters of 1.0 g/t Gold Near Surface
-
Bay Area Transit Transformation Gets $18 Million Boost
-
Zach King Inspires Biola University's 2024 Graduates With Commencement Speech
-
Alibaba Group Prices US$4,500 Million Offering of Convertible Senior Notes
-
Plurilock Announces Amendment to Terms of Convertible Debentures and Warrant Inducement Program and Closing of Debt Settlement
-
FruchtExpress Grabher Launches All-Cash Take-Over Bid for Commander Resources, Invites Shareholders to Tender to the Bid
-
CNOOC Limited Subsidiaries Signed EPCCs with MIREME and ENH
-
Transcenta Debuts Encouraging Phase II Data from First-line Triple Combo Trial of Osemitamab (TST001) for G/GEJ Cancer at ASCO 2024
-
HUTCHMED Highlights Presentations at the 2024 ASCO Annual Meeting
-
C1 Receives Court Approval for Prepackaged Financial Restructuring Plan
-
Journey Energy Inc. Reports on Voting from the 2024 Annual Shareholders Meeting
-
CCL Industries Inc. Announces TSX Acceptance of Normal Course Issuer Bid
-
Jaguar Health to Initiate Commercial Footprint in Cancer Supportive Care at American Society of Clinical Oncology (ASCO) Annual Meeting with Exhibit Booth for FDA-Approved Gelclair Oral Mucositis Prod
-
Aytu BioPharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
-
Highlander Silver Announces Acquisition of the Bonanza Grade San Luis Epithermal Gold-Silver Project in Peru, With Historical Measured & Indicated Resources of 348,000 Ounces Grading 22.4 g/t Gold, an
-
Silver X Mining Announces Strategy Update to Mineral Resource for 2024-2025 Following Social Agreement Signing
-
CCL Industries Inc. Announces TSX Acceptance of Normal Course Issuer Bid
-
Jaguar Health to Initiate Commercial Footprint in Cancer Supportive Care at American Society of Clinical Oncology (ASCO) Annual Meeting with Exhibit Booth for FDA-Approved Gelclair Oral Mucositis Prod

